Publication Name	World Journal of Clinical Cases
Manuscript ID	78504
Country	China

Received	2022-06-30 02:42
Peer-Review Started	2022-06-30 02:45
To Make the First Decision
Return for Revision	2022-08-21 11:05
Revised	2022-08-30 01:21
Second Decision	2022-10-17 03:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-10-17 07:15
Articles in Press	2022-10-17 07:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-10-19 09:07
Publish the Manuscript Online	2022-11-08 07:44

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biochemistry & Molecular Biology
Manuscript Type	Review
Article Title	Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment
Manuscript Source	Unsolicited Manuscript
All Author List	Nan-Lin Li, Mei-Ling Huang and Guang-Tai Shen
ORCID	Author(s) ORCID Number Nan-Lin Li http://orcid.org/0000-0001-7232-0159 Mei-Ling Huang http://orcid.org/0000-0002-6935-3651
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81472598 Project of Xijing Hospital No.XJZT18MJ30
Corresponding Author	Nan-Lin Li, PhD, Professor, Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, No. 127 Changle West Road, Xi’an 710032, Shaanxi Province, China. linanlingo@126.com
Key Words	Ubiquitin-specific proteases; USPs inhibitors; Breast cancer; Review
Core Tip	Ubiquitin-specific proteases (USPs) are emerging as potential therapeutic targets in many diseases. In breast cancer, several USPs were overexpressed. In this study, we summarize the involvement of USPs in breast cancer and the development of USP inhibitors, providing more reference to discover potent and selective clinical candidates.
Publish Date	2022-11-08 07:44
Citation	Huang ML, Shen GT, Li NL. Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment. World J Clin Cases 2022; 10(32): 11690-11701
URL	https://www.wjgnet.com/2307-8960/full/v10/i32/11690.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i32.11690

Full Article (PDF)	WJCC-10-11690.pdf
Full Article (Word)	WJCC-10-11690.docx
Manuscript File	78504_Auto_Edited-LJH-JLW.docx
Answering Reviewers	78504-Answering reviewers.pdf
Audio Core Tip	78504-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	78504-Conflict-of-interest statement.pdf
Copyright License Agreement	78504-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	78504-Grant application form(s).pdf
Peer-review Report	78504-Peer-review(s).pdf
Scientific Misconduct Check	78504-Bing-Liu JH-2.jpg
Scientific Misconduct Check	78504-CrossCheck.jpg
Scientific Editor Work List	78504-Scientific editor work list.pdf